JK

Jalaj Kumar

Active Director Director DIN 09395927
DIN 09395927 First appointment Nov 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2021
Shareholding value Locked Premium profile

About Jalaj Kumar

Jalaj Kumar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Anilin Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09395927
Primary Designation Director
First Appointment 11 Nov 2021
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Anilin Pharma Private Limited U24239BR2021PTC055101
Director 11 Nov 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Anilin Pharma Private Limited
Premium access

Shareholding and investment profile for Jalaj Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jalaj Kumar

Jalaj Kumar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Anilin Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Jalaj Kumar is associated with 1 company as Director.

Jalaj Kumar has expertise in General Business.

Jalaj Kumar has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available